Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bossuyt

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
United European Gastroenterology Journal|October 6, 2018
Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practiceCatherine Reenaers, Peter Bossuyt, Pieter Hindryckx, et al.
Journal of Crohn'S & Colitis|January 28, 2023
Patient-reported Outcomes and Disability Are Associated with Histological Disease Activity in Patients with Ulcerative Colitis: Results from the APOLLO StudyBram Verstockt, Lieven Pouillon, Florence Ballaux, et al.
Journal of Crohn'S & Colitis|July 23, 2021
Ultra-proactive Therapeutic Drug Monitoring of Infliximab Based on Point of Care Testing in Inflammatory Bowel Disease: Results of a Pragmatic TrialPeter Bossuyt, Lieven Pouillon, Sophie Claeys, et al.
Gastroenterology|June 27, 2025
Inflammation Is a Large Dataset of Heartbeats, Groceries, Night Rest, and MorePeter Bossuyt, Ignace De Nollin, Thomas De Moor, et al.
Endoscopy International Open|January 15, 2024
Long-term follow-up of the red density pilot trial: a basis for long-term prediction of sustained clinical remission in ulcerative colitis?Pieter Sinonquel, Peter Bossuyt, João Pedro Guedelha Sabino, et al.
BMC Health Services Research|December 23, 2025
Multi-stakeholder validation of an evidence-based core set of quality indicators for IBD in BelgiumLiselotte Fierens, Frank E Rademakers, Peter Bossuyt, et al.
Inflammatory Bowel Diseases|December 4, 2019
Letter to the Editor: Feasibility and Efficiency of an E-Health Preadmission Assessment System for Intravenous Therapy in Inflammatory Bowel DiseaseLieven Pouillon, Eveline Hoefkens, Veronique Verheyen, et al.
European Journal of Gastroenterology & Hepatology|February 21, 2018
The operative risk and natural history after the diagnosis of ileal penetrating Crohn's diseasePeter Bossuyt, Celine Debeuckelaere, Marc Ferrante, et al.
European Journal of Gastroenterology & Hepatology|March 7, 2019
Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decadesAnnick Moens, Bram Verstockt, Kathleen Machiels, et al.
European Journal of Gastroenterology & Hepatology|June 25, 2024
Development of a set of measurable outcome indicators for Flemish patients with inflammatory bowel diseaseLiselotte Fierens, Peter Bossuyt, Filip Baert, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
United European Gastroenterology Journal|October 6, 2018
Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practiceCatherine Reenaers, Peter Bossuyt, Pieter Hindryckx, et al.
Journal of Crohn'S & Colitis|January 28, 2023
Patient-reported Outcomes and Disability Are Associated with Histological Disease Activity in Patients with Ulcerative Colitis: Results from the APOLLO StudyBram Verstockt, Lieven Pouillon, Florence Ballaux, et al.
Journal of Crohn'S & Colitis|July 23, 2021
Ultra-proactive Therapeutic Drug Monitoring of Infliximab Based on Point of Care Testing in Inflammatory Bowel Disease: Results of a Pragmatic TrialPeter Bossuyt, Lieven Pouillon, Sophie Claeys, et al.
Gastroenterology|June 27, 2025
Inflammation Is a Large Dataset of Heartbeats, Groceries, Night Rest, and MorePeter Bossuyt, Ignace De Nollin, Thomas De Moor, et al.
Endoscopy International Open|January 15, 2024
Long-term follow-up of the red density pilot trial: a basis for long-term prediction of sustained clinical remission in ulcerative colitis?Pieter Sinonquel, Peter Bossuyt, João Pedro Guedelha Sabino, et al.
BMC Health Services Research|December 23, 2025
Multi-stakeholder validation of an evidence-based core set of quality indicators for IBD in BelgiumLiselotte Fierens, Frank E Rademakers, Peter Bossuyt, et al.
Inflammatory Bowel Diseases|December 4, 2019
Letter to the Editor: Feasibility and Efficiency of an E-Health Preadmission Assessment System for Intravenous Therapy in Inflammatory Bowel DiseaseLieven Pouillon, Eveline Hoefkens, Veronique Verheyen, et al.
European Journal of Gastroenterology & Hepatology|February 21, 2018
The operative risk and natural history after the diagnosis of ileal penetrating Crohn's diseasePeter Bossuyt, Celine Debeuckelaere, Marc Ferrante, et al.
European Journal of Gastroenterology & Hepatology|March 7, 2019
Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decadesAnnick Moens, Bram Verstockt, Kathleen Machiels, et al.
European Journal of Gastroenterology & Hepatology|June 25, 2024
Development of a set of measurable outcome indicators for Flemish patients with inflammatory bowel diseaseLiselotte Fierens, Peter Bossuyt, Filip Baert, et al.
Pageof 14